Applications of (±)-Cloprostenol Sodium Salt in Industrial Manufacturing

(±)-Cloprostenol Sodium Salt is widely used as a key pharmaceutical intermediate and active substance in veterinary hormone preparations. Our factory supplies this compound with strict process control and validated batch consistency for licensed downstream industrial users in animal health and reproductive technologies. Below, we detail major downstream sectors, focused on regulatory standards, process flow, and final product formats.

1. Veterinary Reproductive Hormone Preparations

Major animal health manufacturers incorporate this compound as a luteolytic agent in injectable and intramuscular formulations for cattle, swine, sheep, and goats. It modulates the reproductive cycle, supporting synchronization protocols for estrus, inducing parturition, and assisting with uterine health management. Integrated QC tracks both API stability and residue safety for veterinary pharmaceuticals, ensuring alignment with authorized livestock use.

Industry compliance standards

• European Pharmacopoeia (Ph. Eur.) veterinary monographs
• USP Veterinary Drug Standards
• China Veterinary Pharmacopoeia (CVP)
• Good Manufacturing Practice (GMP) for Veterinary Products (EU Directive 91/412/EEC, FDA cGMP 21 CFR Part 211)

Typical usage ratio

• 0.075–0.25 mg per dose, formulated as 0.2 mg/mL or 0.5 mg/mL injectable solutions; concentration adjusted per species guidelines and product shelf-life requirements

Downstream process integration

• Direct dissolution into sterile aqueous solution during pharmaceutical compounding
• Sterile filtration and aseptic filling
• Stability and residue testing prior to lot release

Final product types

• Veterinary estrus synchronization injections
• Prostaglandin-based reproductive management solutions
• Uterine health therapeutics for livestock

2. Livestock Artificial Insemination Protocols

Livestock breeding equipment suppliers utilize this compound within hormonal induction kits for estrus and ovulation synchronization in cattle and swine. It enables controlled breeding scheduling, improving pregnancy rates at commercial farms and AI centers. Regulatory records document batch tracking and residue withdrawal periods for each batch dispatched to authorized semen processing or animal breeding facilities.

Industry compliance standards

• OIE Terrestrial Manual guidelines on reproductive hormone use
• EU Rules for Veterinary Medicinal Products (Regulation (EU) 2019/6)
• USDA Center for Veterinary Biologics requirements

Typical usage ratio

• Administered at 0.15–0.25 mg per animal per dose, typically diluted in saline to achieve uniform hormone delivery in multi-dose vials; daily usage tailored to total herd protocol scale

Downstream process integration

• Blending into ready-to-use AI synchronization kits or hormonal protocols
• Sterilization through filtration or autoclaving, based on end-use kit design
• Unit dose packaging for field veterinarians and technicians

Final product types

• Estrus synchronization kits for dairy and beef cattle
• Pre-mixed hormone programs for commercial swine reproduction
• Timed artificial insemination scheduling reagents

3. Biopharmaceutical Contract Manufacturing for Active Ingredient Supply

Licensed animal health pharmaceutical companies subcontract synthesis and bulk supply to our manufacturing site, where we conduct synthesis, purification, and bulk API release under international GMP audit. Our manufacturing process yields stable, high-purity material supported by validated process analytical technology (PAT) and full documentation for regulatory inspection, including impurity profile, residual solvent content, and identity testing per monograph requirements.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia and Chinese Pharmacopoeia API specifications
• GMP Certificate for veterinary APIs (issued by National Medical Products Administration or EMA)

Typical usage ratio

• Supplied as bulk API, 98–102% assay, with batch sizes from 500 g to 10 kg per shipment to downstream formulation sites; API loss on formulation monitored below 1.0% by weight

Downstream process integration

• Direct transfer into pharmaceutical blending for finished veterinary products
• Re-packaging under nitrogen for global export
• Comprehensive COA and traceability documentation provided with each delivery

Final product types

• Finished pharmaceutical hormone products (injectables, lyophilized vials)
• Intermediate bulk solutions for multinational veterinary drug makers
• API reference standards for QC labs

4. Analytical Reference Standard Supply for Regulatory Laboratories

Accredited analytical chemistry laboratories and quality control centers source our material as an officially documented reference substance for residue detection and trace quantification in animal tissues and veterinary drug formulations. Each reference standard batch includes precise purity assays and full analytical characterization data supporting regulatory filings in food safety and pharmaceutical monitoring programs.

Industry compliance standards

• ISO/IEC 17025 accreditation for laboratory reference material supply
• AOAC Official Methods for veterinary hormone residue analysis
• Codex Alimentarius MRL (Maximum Residue Limit) guidelines

Typical usage ratio

• Supplied at >99% purity; reference solutions prepared at 1–10 μg/mL for method calibration; dilution tailored to detection limit for LC-MS/MS or HPLC analysis

Downstream process integration

• Preparation of calibration and quality control samples for LC-MS/MS trace analysis
• Batch comparison for pharmacopoeial monograph validation
• Storage under controlled temperature and humidity conditions

Final product types

• Certified analytical reference standards for regulatory labs
• Residue detection kits supplied to food and pharma monitoring agencies
• Working standards for veterinary QC method validation